Literature DB >> 28778721

Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease.

Sakyo Hirai1, Motoki Inaji2, Yoji Tanaka1, Shoko Hara1, Tadashi Nariai1, Taketoshi Maehara1.   

Abstract

BACKGROUND: The examination of cerebral hemodynamics is indispensable for the clinical management of patients with moyamoya disease (MMD). In this study, we examined the correlation between clinical presentations and hemodynamic parameters measured by dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) in adult patients with MMD.
METHODS: One hundred fifty-seven hemispheres in 122 adult patients with MMD were examined by DSC-MRI to measure the regional relative cerebral blood volume (CBV) and relative mean transit time (MTT). The patients were divided into 4 groups based on their clinical presentations: a nonsymptomatic (NS), hemorrhagic (H), infarction (I), and transient ischemic attack (T) group. The regional CBV and MTT values were compared among the 4 groups.
RESULTS: The relative value of CBV was significantly higher in groups T and I than in the NS group (P < .01). The CBV of group H was higher than that of the NS group only in the frontal lobe cortex. There were no significant statistical differences among the 3 symptomatic groups. Prolongation of the MTT in comparison with the cerebellum (MTT delay) was significantly higher in groups T and I than in the NS group in all regions of the cerebral cortex (P < .05). The MTT delay was significantly lower in group H than in group T in the frontal lobe and the Rolandic area (P < .05).
CONCLUSIONS: Hemodynamic factors measured by DSC-MRI reflected the variable clinical presentations of patients with MMD. DSC-MRI is a useful modality for evaluating the clinical conditions of individual adult patients with MMD.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DSC-MRI; Moyamoya disease; cerebral hemodynamics; clinical presentation

Mesh:

Substances:

Year:  2017        PMID: 28778721     DOI: 10.1016/j.jstrokecerebrovasdis.2017.06.057

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

1.  Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with 15O-Gas PET and Singular Value Decomposition.

Authors:  S Hara; Y Tanaka; S Hayashi; M Inaji; T Maehara; M Hori; S Aoki; K Ishii; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-10       Impact factor: 3.825

2.  Myelin and Axonal Damage in Normal-Appearing White Matter in Patients with Moyamoya Disease.

Authors:  S Hara; M Hori; A Hagiwara; Y Tsurushima; Y Tanaka; T Maehara; S Aoki; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-27       Impact factor: 3.825

3.  The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.

Authors:  Hongtao Zhang; Mingming Lu; Shitong Liu; Dongqing Liu; Xuxuan Shen; Fugeng Sheng; Cong Han; Jianming Cai
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.